Related Experiment Video
Updated: Feb 10, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge
Lori Dupree1, Marci DeLosSantos2, Carmen Smotherman3
11 Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, UF Health Jacksonville, FL, USA.
Insights
Most atrial fibrillation patients receive appropriate stroke prevention therapy. However, withholding anticoagulation due to fall risk needs reconsideration, given its benefits in preventing atrial fibrillation stroke.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Atrial fibrillation (AF) necessitates risk stratification for stroke prevention.
- Antithrombotic therapy is crucial for managing AF-related stroke risk.
Purpose of the Study:
- To assess adherence to guideline-directed antithrombotic therapy in atrial fibrillation (AF) patients upon hospital discharge.
- To evaluate therapy adherence based on the CHA₂DS₂-VASc score.
Main Methods:
- Retrospective analysis of 293 AF patients discharged between June 2014 and June 2016.
- Collected demographic data, CHA₂DS₂-VASc scores, and reasons for withholding antithrombotic therapy (e.g., bleeding risk, falls).
Main Results:
- 63% of AF patients received appropriate antithrombotic therapy at discharge; 50% had a CHA₂DS₂-VASc score ≥2.
- When documented reasons for withholding anticoagulation were considered appropriate, 81% of patients were on suitable therapy (OR: 1.57, P < .0001).
- Bleeding risk and falls were the primary reasons for withholding anticoagulation.
Conclusions:
- The majority of AF patients are discharged on appropriate antithrombotic therapy based on CHA₂DS₂-VASc risk stratification.
- Reconsideration of withholding anticoagulation due to fall risk is recommended, balancing benefits against stroke prevention in AF.
Background:
Risk stratification for stroke in patients with atrial fibrillation is a vital step in identifying whether antithrombotic therapy is indicated for stroke prevention in this common arrhythmia.
Purpose:
The aim of this study was to determine adherence to guideline-directed antithrombotic therapy based on Congestive Heart Failure (1 point), Hypertension (1 point), Age (≥75 years old is 2 points and 65-74 is 1 point), Diabetes (1 point), prior Stroke (2 points), Vascular Disease (1 point), and Sex Category (1 point if female; CHA2DS2-VASc) score in patients with atrial fibrillation (AF) on hospital discharge.
Methods:
A total of 293 patients discharged from this academic medical center with a history of atrial fibrillation from June 2014 to June 2016 were enrolled. Demographic data and indicators for antithrombotic therapy based on the CHA2DS2-VASc score were recorded, and factors that affected adherence to guideline-directed therapy, such as bleeding risk, falls, and alcohol abuse, were collected and analyzed.
Results:
At hospital discharge, 63% of patients with AF were on appropriate antithrombotic therapy, 50% with a CHA2DS2-VASc score ≥2. The odds ratio of appropriate therapy in patients with a CHA2DS2-VASc score ≥2 was 1.17 (95% confidence interval [CI]: 0.95-1.30; P = .18). When chart documentation for reasons to withhold anticoagulation was considered as appropriate therapy, 81% of patients with AF were discharged on appropriate antithrombotic therapy with an odds ratio of 1.57 (95% CI: 1.26 -1.96, P < .0001), with bleeding and falls risk as the most common reasons to withhold anticoagulation.
Conclusion:
Based on risk stratification of stroke through the CHA2DS2-VASc score, the majority of patients with AF were discharged from the hospital on appropriate antithrombotic therapy. Withholding anticoagulation due to falls risk should be reconsidered as a result of the known benefits of stroke prevention in atrial fibrillation.
Related Concept Videos
Hospitals-II
Nurses that work in...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Hospitals-I
Discharge Summary Forms
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Evaluating Limits by Direct Substitution

